Previous Close | 0.0450 |
Open | 0.0450 |
Bid | 0.0400 x N/A |
Ask | 0.0450 x N/A |
Day's Range | 0.0400 - 0.0450 |
52 Week Range | 0.0300 - 0.1950 |
Volume | |
Avg. Volume | 71,585 |
Market Cap | 3.749M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) ("Pathway" or the "Corporation") is pleased to provide an update on its proposed acquisition of all the issued and outstanding common shares of each of HEAL Global Holdings Corp. ("HEAL") and The Newly Institute Inc. ("The Newly") from their respective shareholders in exchange for common shares in the capital of Pathway to be completed by way of an arrangement ("Proposed Transaction") pursuant to a plan of arrangement under the Business Corporati
Pathway Health Corp. (TSXV: PHC) (Frankfurt: KL1) ("Pathway" or the "Company") is pleased to announce that, further to its press releases of February 3, 2023 and February 9, 2023, it has made its second draw down in the amount of $500,000 (the "Draw Down") under the $1.25 million secured convertible promissory grid note (the "Note") with HEAL Global Holdings Corp. (the "Lender"), an entity controlled by the Company's largest indirect beneficial shareholder Avonlea-Drewry Holdings Inc., and which
Pathway Health Corp. (TSXV: PHC) ("Pathway" or the "Company") is pleased to announce that, further to its press release of February 3, 2023, it has elected to draw down $500,000 (the "Draw Down") under the $1.25 million secured convertible promissory grid note (the "Note") with HEAL Global Holdings Corp. (the "Lender"), an entity controlled by the Company's largest indirect beneficial shareholder Avonlea-Drewry Holdings Inc., and which is a party to the Company's previously announced letter of i